Apples and oranges? A comparison of BEST-CLI to BASIL-2 #JVascSurg #UCSFVascular

Insightful, data-rich commentary as expected from our flowmigos Conte and O'Banion The Battle of the Limb Preservation Trials: BEST-CLI vs. BASIL-2 Two major randomized clinical trials comparing endovascular and open surgical approaches for patients with chronic limb-threatening ischemia (CLTI) - BEST-CLI and BASIL-2 - reported seemingly contradictory results recently. In the larger BEST-CLI trial, patients... Continue Reading →

Relationship between WIfI Stage and Quality of Life at the time of Revascularization in the @BEST_CLI Trial #ActAgainstAmputation @ALPSlimb

Another important contribution to the literature from the Best CLI trial from Jeff Syracuse and coworkers. Type of Research: This is prospectively collected data from a randomized clinical trial. Key Findings: Patients presenting with WIfI stage 4 were more often current smokers, had end stage renal disease, diabetes, and were not independently ambulatory. WIfI stage 4, compared... Continue Reading →

BEST-CLI: The results are in and they’re likely practice-altering ActAgainstAmputation @ALPSlimb @Best_CLI #AHA22

This from our colleagues Alik Farber, Matt Menard and Ken Rosenfeld. Likely to be a game-changer in how patients with CLTI are addressed. The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV) is a more effective revascularisation strategy for patients with chronic limb-threatening ischaemia (CLTI) who are deemed to be suitable... Continue Reading →

Up ↑

%d bloggers like this:
Verified by MonsterInsights